287 related articles for article (PubMed ID: 12796206)
1. Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma.
Passero M; Chowdhry S
Chest; 2003 Jun; 123(6):2155-6; author reply 2156. PubMed ID: 12796206
[No Abstract] [Full Text] [Related]
2. COX-1 sparing drugs in aspirin-sensitive asthma.
Picado C; Valero A
Clin Exp Allergy; 2001 Feb; 31(2):179-81. PubMed ID: 11251618
[No Abstract] [Full Text] [Related]
3. The importance of COX-2 inhibition for aspirin induced asthma.
Bennett A
Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S54-6. PubMed ID: 10992560
[No Abstract] [Full Text] [Related]
4. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
Marks F; Harrell K; Fischer R
South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 inhibitors in aspirin-induced asthma.
Inoue K; Takano H; Kawahito Y; Sano H; Yoshikawa T
Chest; 2003 Apr; 123(4):1317-8; author reply 1318. PubMed ID: 12684334
[No Abstract] [Full Text] [Related]
6. Aspirin and NSAID sensitivity.
Stevenson DD
Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
[TBL] [Abstract][Full Text] [Related]
7. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
Baigent C; Patrono C
Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
[No Abstract] [Full Text] [Related]
8. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.
Hawk ET; Viner JL; Umar A
Prog Exp Tumor Res; 2003; 37():210-42. PubMed ID: 12795057
[No Abstract] [Full Text] [Related]
9. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
Szczeklik A; Sanak M
Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
[No Abstract] [Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction.
Hawkey CJ
Am J Med; 2001 Jan; 110(1A):1S-3S. PubMed ID: 11165986
[No Abstract] [Full Text] [Related]
11. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
12. COX-2 inhibitors: a review.
Houston AM; Teach SJ
Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
[No Abstract] [Full Text] [Related]
13. Beneficial effect of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with asthma during viral infection.
Varner AE
J Infect Dis; 2002 Sep; 186(5):723; author reply 723-4. PubMed ID: 12195364
[No Abstract] [Full Text] [Related]
14. A magic bullet for mucosal protection...and aspirin is the trigger!
Wallace JL; Fiorucci S
Trends Pharmacol Sci; 2003 Jul; 24(7):323-6. PubMed ID: 12871661
[No Abstract] [Full Text] [Related]
15. Is there a place for non-selective NSAIDs in the treatment of arthritis?
Crofford LJ
Joint Bone Spine; 2002 Jan; 69(1):4-7. PubMed ID: 11858355
[No Abstract] [Full Text] [Related]
16. [COX-2 inhibitor to whom?].
Martio J
Duodecim; 2000; 116(12):1265-7. PubMed ID: 11988961
[No Abstract] [Full Text] [Related]
17. Cardiovascular events and COX-2 inhibitors.
Singh G
JAMA; 2001 Dec; 286(22):2810-1; author reply 2811-2. PubMed ID: 11735748
[No Abstract] [Full Text] [Related]
18. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
Feldman M; McMahon AT
Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
[No Abstract] [Full Text] [Related]
19. COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease.
Crofford LJ
Arthritis Res Ther; 2003; 5(1):25-7. PubMed ID: 12716444
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
Patrono C
Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
